Pharmaceuticals: Major
Polish companies operating in the same pharmaceuticals: major industry
The table below has Polish companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as MedTech Solutions S.A.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LILYEli Lilly and Company | 4.16 T PLN | 4,377.5 PLN | 0.00% | 0 | 0.00 | 39.49 | 110.86 PLN | +103.70% | 0.58% | Health technology | Buy |
 NVONovo Nordisk A/S Class B | 669.29 B PLN | 150.88 PLN | 0.00% | 30 | 0.12 | 10.04 | 15.03 PLN | +6.16% | 4.16% | Health technology | Neutral |
 BAYBayer AG | 209.62 B PLN | 212.4 PLN | 0.00% | 0 | 0.00 | — | −7.61 PLN | +48.54% | 0.23% | Health technology | Buy |
 KRKKrka, d. d., Novo mesto | 35.25 B PLN | 1,148 PLN | +1.59% | 1 | 0.02 | 19.39 | 59.22 PLN | +12.03% | 3.50% | Health technology | Buy |
 SPHSopharma AD | 5.58 B PLN | 10.10 PLN | 0.00% | 0 | 0.00 | 15.71 | 0.64 PLN | +54.44% | 3.85% | Health technology | No rating |
 CLNCelon Pharma SA | 1.05 B PLN | 19.62 PLN | +1.13% | 642 | 0.03 | 9.59 | 2.05 PLN | — | 0.00% | Health technology | Neutral |
 CTXCaptor Therapeutics SA | 454.27 M PLN | 70.2 PLN | −1.82% | 86 | 0.02 | — | −7.87 PLN | −4.61% | 0.00% | Health technology | Strong buy |
 BCXBioceltix SA | 416.58 M PLN | 75.3 PLN | 0.00% | 244 | 0.09 | — | −3.32 PLN | −4.21% | 0.00% | Health technology | Strong buy |
 RVURyvu Therapeutics SA | 367.61 M PLN | 16.18 PLN | +1.76% | 1.34 K | 0.05 | — | −2.94 PLN | +43.60% | 0.00% | Health technology | Buy |
 BIOBIOTON S.A. | 302.67 M PLN | 3.590 PLN | +1.84% | 965 | 0.02 | — | −0.10 PLN | +19.59% | 0.00% | Health technology | No rating |
 SVESYNTHAVERSE Spolka Akcyjna | 218.18 M PLN | 2.900 PLN | +1.05% | 1.27 K | 0.05 | — | −0.32 PLN | −401.05% | 0.00% | Health technology | Sell |
 MOCMolecure SA | 191.61 M PLN | 7.60 PLN | −1.94% | 5.64 K | 0.05 | — | −0.71 PLN | +60.22% | 0.00% | Health technology | Strong buy |
 BGDBiogened SA | 49.62 M PLN | 20.2 PLN | 0.00% | 0 | 0.00 | 10.32 | 1.96 PLN | +4.98% | 4.95% | Health technology | No rating |
 SCSStem Cells Spin SA | 39.17 M PLN | 0.500 PLN | +6.38% | 66 | 0.10 | — | — | — | — | Health technology | No rating |
 MDTMedTech Solutions S.A. | 26.27 M PLN | 0.346 PLN | −0.57% | 112.36 K | 0.16 | — | −0.04 PLN | +5.77% | 0.00% | Health technology | No rating |
 MDBMedicofarma Biotech Spolka Akcyjna | 24.88 M PLN | 0.378 PLN | +3.28% | 100 | 0.01 | — | −0.03 PLN | +36.86% | 0.00% | Health technology | No rating |
 SNGSYNERGA.fund SA | 12.13 M PLN | 0.444 PLN | 0.00% | 2.52 K | 0.39 | — | — | — | — | Health technology | No rating |
 S2BSyn2bio Spolka Akcyjna | — | 75.20 PLN | +1.51% | 5.17 K | 0.10 | — | — | — | — | Health technology | Strong buy |